FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

Brazilian authorities said the death was unlikely to have been caused by Elevidys and was instead more in line with severe ...

William Blair has named Brent Gledhill as CEO. He will be succeeding John Ettelson, who has been appointed William Blair’s chairman. Gledhill joined William Blair as an investment banker in ...

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

William Blair on Monday upgraded Stitch Fix (SFIX) shares to 'Outperform' from 'Market Perform,' sending the stock up nearly ...

William Blair’s investment banking group enables corporations, financial sponsors, and owner/entrepreneurs around the world to achieve their growth, liquidity, and financing objectives.

Fintel reports that on July 25, 2025, William Blair downgraded their outlook for Ameriprise Financial (NYSE:AMP) from ...

The William Blair venture that utilizes InvestCloud's cloud-based technology was created to give advisors access to a suite of proprietary software aimed at streamlining day-to-day operations and ...

William Blair is raising salaries from analysts to managing directors. First-year analysts will make $110,000, ahead of the new market standard for pay.

He was preceded in death by sons William Blair III and Jordan Blair. Advertisement “He was a Renaissance man,” said Gregory Jordan, a nephew.